WHO recommends rollout of new malaria vaccine to prevent childhood deaths

The World Health Organization has recommended a second, more affordable malaria vaccine called R21/Matrix-M.
The vaccine was developed by Oxford University and the Serum Institute of India, and has shown high efficacy in clinical trials.
R21/Matrix-M is expected to be rolled out in some African countries beginning in 2024, pending funding.
The new vaccine could help close the gap in supply and demand alongside the previously recommended RTS,S vaccine.
WHO says both vaccines are safe and effective options to help prevent malaria, which killed over 600,000 people in 2021.